Search Results Search Sort by RelevanceMost Recent Viewpoint Sep 2007 Gamete Donation, Identity, and the Offspring's Right to Know Lucy Frith The ethical reasons for making gamete donation nonanonymous and allowing offspring to have access to donor information. Virtual Mentor. 2007;9(9):644-648. doi: 10.1001/virtualmentor.2007.9.9.oped1-0709. Case and Commentary Jan 2006 Breast Cancer Screening, Commentary 2 Antonella Surbone, MD, PhD Physicians need to counsel patients about the limitations of genetics test results and what the results mean in terms of a clinical prognosis. Virtual Mentor. 2006;8(1):10-15. doi: 10.1001/virtualmentor.2006.8.1.ccas1-0601. Case and Commentary Jan 2006 Breast Cancer Screening, Commentary 1 Heidi Malm, PhD and Gerald W. Chodak, MD Physicians need to counsel patients about the limitations of genetics test results and what the results mean in terms of a clinical prognosis. Virtual Mentor. 2006;8(1):7-10. doi: 10.1001/virtualmentor.2006.8.1.ccas1-0601. Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly. Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408. Medicine and Society May 2003 Assisted Reproductive Technologies, Sex Selection, and the Commodification of Children Timothy F. Murphy, PhD The possibilities of pre-conception selection of gender and character traits of children pose many moral and ethical questions. Virtual Mentor. 2003;5(5):190-192. doi: 10.1001/virtualmentor.2003.5.5.msoc1-0305. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2
Viewpoint Sep 2007 Gamete Donation, Identity, and the Offspring's Right to Know Lucy Frith The ethical reasons for making gamete donation nonanonymous and allowing offspring to have access to donor information. Virtual Mentor. 2007;9(9):644-648. doi: 10.1001/virtualmentor.2007.9.9.oped1-0709.
Case and Commentary Jan 2006 Breast Cancer Screening, Commentary 2 Antonella Surbone, MD, PhD Physicians need to counsel patients about the limitations of genetics test results and what the results mean in terms of a clinical prognosis. Virtual Mentor. 2006;8(1):10-15. doi: 10.1001/virtualmentor.2006.8.1.ccas1-0601.
Case and Commentary Jan 2006 Breast Cancer Screening, Commentary 1 Heidi Malm, PhD and Gerald W. Chodak, MD Physicians need to counsel patients about the limitations of genetics test results and what the results mean in terms of a clinical prognosis. Virtual Mentor. 2006;8(1):7-10. doi: 10.1001/virtualmentor.2006.8.1.ccas1-0601.
Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly. Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408.
Medicine and Society May 2003 Assisted Reproductive Technologies, Sex Selection, and the Commodification of Children Timothy F. Murphy, PhD The possibilities of pre-conception selection of gender and character traits of children pose many moral and ethical questions. Virtual Mentor. 2003;5(5):190-192. doi: 10.1001/virtualmentor.2003.5.5.msoc1-0305.